Status:
COMPLETED
Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections
Lead Sponsor:
Cairo University
Conditions:
The Quality of Recovery (ObsQOR-11)
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
The study hypothesizes that addition of dexmedetomidine to bupivacaine either in spinal anesthesia or TAP block is more effective and provide better ObsQor-11score than bupivacaine alone. Also, Dexmed...
Detailed Description
Aim of the work To compare the quality of recovery (ObsQOR-11) in patients undergoing cesarean sections receiving dexmedetomedine either intrathecally or in the tap block in comparison to patients rec...
Eligibility Criteria
Inclusion
- Participants will be full-term pregnant females
- ASA classification I or ll.
- Aged between 18 and 40 years.
- Singleton pregnancy
Exclusion
- Refusal of block.
- Bleeding disorders (platelets count \<150,000; INR\>1.5; PC\<60%).
- wounds or infection at the puncture site.
- Known allergy to local anesthetic drugs.
- Contraindications to neuroaxial block.
- Contraindications to TAP block..
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT05991466
Start Date
January 1 2022
End Date
December 31 2022
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Cairo University
Cairo, Cairo Governorate, Egypt, 11562